ENDONOVO THERAPEUTICS, INC. Note Agreements

10 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Endonovo Therapeutics, Inc. 10% Senior Secured Convertible Redeemable Note Due November 30, 2019 (Eagle Equities, LLC)
Note Agreements
ENDONOVO THERAPEUTICS, INC.
Biotechnology
2018
Form of Back End Note under the SPA
Note Agreements
ENDONOVO THERAPEUTICS, INC.
Biotechnology
2018
Form of Note Payable to Eagle under the SPA
Note Agreements
ENDONOVO THERAPEUTICS, INC.
Biotechnology
2018
Endonovo Therapeutics, Inc. 10% Convertible Secured Redeemable Note Due December 21, 2018 (Eagle Equities, LLC)
Note Agreements
ENDONOVO THERAPEUTICS, INC.
Biotechnology
2017
Secured Promissory Note, dated December 22, 2017, payable to Steven Gluckstern
Note Agreements
ENDONOVO THERAPEUTICS, INC.
Biotechnology
2017
Endonovo Therapeutics, Inc. 10% Convertible Redeemable Note Due April 7, 2018 (Eagle Equities, LLC)
Note Agreements
ENDONOVO THERAPEUTICS, INC.
Biotechnology
2017
Endonovo Therapeutics, Inc. 10% Convertible Redeemable Note Due April 7, 2018 (Eagle Equities, LLC)
Note Agreements
ENDONOVO THERAPEUTICS, INC.
Biotechnology
2017
6% Senior Convertible Note between Endonovo Therapeutics, Inc. and Bellridge LP dated July 8, 2016
Note Agreements
ENDONOVO THERAPEUTICS, INC.
Biotechnology
NY
2016
Promissory Note between Endonovo Therapeutics, Inc. and Holders of Rio Grande Neurosciences, Inc. Stock Dated July 9, 2016
Note Agreements
ENDONOVO THERAPEUTICS, INC.
Biotechnology
2016
$250,000 10% Convertible Promissory Note between Endonovo Therapeutics, Inc. and Regal Consulting
Note Agreements
ENDONOVO THERAPEUTICS, INC.
Biotechnology
NV
2016